집
처방전 심사 보조
의료 건강
4
4
임상 지침에 따라 금기 사항 및 상호 작용을 자동으로 확인하여 약물 안전성을 보장합니다.
프롬프트 내용
복사
복사
Act as a senior clinical pharmacist and review the following prescription for compliance: The patient is a 65-year-old male with a history of chronic kidney disease (creatinine clearance 45ml/min) and hypertension. The current prescription includes Amoxicillin, Amlodipine, and Ibuprofen. Focus on analyzing drug-drug interactions, the necessity for dosage adjustments, and potential nephrotoxicity risks, providing recommendations aligned with clinical guidelines.
복사
시니어 임상 약사로서 다음 환자의 처방전이 규정 준수 여부를 검토하십시오. 환자는 65세 남성으로 만성 신장 질환(크레아티닌 청소율 45ml/min)과 고혈압 병력이 있습니다. 현재 처방에는 아목시실린, 암로디핀, 이부프로펜이 포함되어 있습니다. 약물 상호 작용, 용량 조정의 필요성, 잠재적 신독성 위험에 중점을 두고 분석하며, 임상 지침에 부합하는 약물 사용 조언을 제공하십시오.
복사
의견 (0)
0/300
추천
처방전 감사 어시스턴트
Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, contraindication conflicts, and whether the dosage aligns with the patient's age and hepatic/renal function. Provide adjustment suggestions or risk warnings based on the latest clinical guidelines to ensure the safety and efficacy of the medication regimen.
처방전 심사 어시스턴트
Act as a senior clinical pharmacist to evaluate the patient's basic information, medical history, and the proposed medication list. Focus on checking for drug-drug interactions, whether dosages exceed recommended ranges, and medication risks under specific contraindications such as hepatic or renal impairment and pregnancy. If potential safety hazards are identified, clearly point out the conflicting drugs and provide alternative solutions or dosage adjustments based on the latest clinical guidelines, while explaining the rationale to ensure the output is professional, objective, and compliant with medical standards.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided electronic prescription data for compliance. Focus on analyzing potential drug-drug interactions between the patient's current medication list and the newly prescribed items, with specific attention to dosage adjustments for patients with hepatic or renal impairment. Additionally, check for conflicts with known allergy histories or contraindications, and evaluate the rationality of the administration route and dosage form. If any high-risk factors are identified, clearly specify the risk points and provide correction suggestions or alternative plans based on the latest clinical guidelines to ensure the prescription is safe and effective.
처방전 감사 어시스턴트
Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract the patient's basic information, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical medication guidelines and package inserts, check each item for contraindications, drug interactions, or overdose risks. Finally, if potential risks are found, clearly point out the issues and provide specific adjustment suggestions or alternative plans; if the prescription is compliant, confirm its rationality. The output must include patient profile, identified issues (if any), and the final professional audit conclusion, ensuring the language is professional, objective, and easy for doctors to understand.
처방전 심사 보조
Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and Ibuprofen 400mg three times daily for joint pain. Please analyze if there are potential drug-disease interactions, drug-drug interactions, or inappropriate dosing risks in this prescription, particularly regarding the use of NSAIDs in patients with renal insufficiency, and provide adjustment suggestions or warnings to ensure medication safety.
처방전 심사 어시스턴트
Act as a senior clinical pharmacist. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, to audit the proposed prescription. Focus on analyzing drug-drug interaction risks, checking if dosages exceed renal adjustment limits, and identifying absolute contraindications. Finally, output a standardized audit report containing risk assessment levels and specific adjustment recommendations to ensure medication safety.
